⌕
AbCellera Biologics · ABCL · Nasdaq
$10.9515-min delayed· as of Nov 17, 2026Tenet 49 · Mixed
Compare
$10.9515-min delayedTenet 49 · Mixed

AbCellera Biologics (ABCL) Stock

AbCellera Biologics (ABCL) has a Tenet Score of 49 of 100 against 340 Healthcare peers, as of Nov 16, 2026.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

24 figures withheld by our checks. Each blank figure names its reason.

Key stats

Market cap
$3.6B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
2.75 – 15.02
low → high · as of close, Nov 16, 2026
Tenet Score
49/100
Mixed · 340 Healthcare peers

Industry: Health Services

AbCellera Biologics Inc scores 49/100. Mixed. Strongest on financial health, growth is the soft spot versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
49/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
60
Quality
40
Health
88
Growth
9

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueCQualityDHealthBGrowthFMomentumA+
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
3.4×
Sep 30, 2026 balance sheet
P/S
53.5×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
−15%
TTM through Sep 30, 2026
Operating margin
−289.0%
fiscal 2025, before interest and tax
Net margin
−218.5%
TTM through Sep 30, 2026
Current ratio
12.43
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About AbCellera Biologics Inc

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As o…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 11 US ETFs · top wrappers by weightSee all ETFs holding ABCL →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is AbCellera Biologics in?

AbCellera Biologics is in the Healthcare sector and the Health Services industry.

What is AbCellera Biologics' Tenet Score?

AbCellera Biologics' Tenet Score is 49 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.